Literature DB >> 2183517

Hepatitis B: the disease.

S Sherlock1.   

Abstract

Hepatitis B virus (HBV) is carried by approximately 300 million people in the world. The natural history of the disease in an individual patient depends on the method by which the infection was acquired, whether perinatal, in childhood, as a result of drug abuse, or in the course of health care work. Other important factors determining the course of the disease include an individual's sex and immunological status. Geographic factors also contribute. Changing lifestyles and the use of prophylactic hepatitis B vaccination affect the prevalence in various groups in the community. The clinical course of the disease, possible complications, and a recent classification system for chronic HBsAg carriers are discussed.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2183517     DOI: 10.1016/0264-410x(90)90206-2

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  7 in total

Review 1.  Pharmacoeconomics of immunisation: a review.

Authors:  R van den Oever; D de Graeve; B Hepp; A Stroobant; D Walckiers; V Van Casteren; F Van Loock; G Ducoffre; J Dewatripont; P Jacques
Journal:  Pharmacoeconomics       Date:  1993-04       Impact factor: 4.981

2.  The dynamics of hepatitis B virus infection.

Authors:  R J Payne; M A Nowak; B S Blumberg
Journal:  Proc Natl Acad Sci U S A       Date:  1996-06-25       Impact factor: 11.205

3.  Vaccine coverage during a school-based hepatitis B immunization program.

Authors:  S L Deeks; I L Johnson
Journal:  Can J Public Health       Date:  1998 Mar-Apr

4.  Ante-natal screening for hepatitis B surface antigen: an appraisal of its value in a low prevalence area.

Authors:  M J Dwyer; P G McIntyre
Journal:  Epidemiol Infect       Date:  1996-08       Impact factor: 2.451

Review 5.  Methodological quality of economic modelling studies. A case study with hepatitis B vaccines.

Authors:  T Jefferson; V Demicheli
Journal:  Pharmacoeconomics       Date:  1998-09       Impact factor: 4.981

Review 6.  Molecular hybridization techniques in current diagnosis of chronic hepatitis B in childhood.

Authors:  S Wirth; B Zabel
Journal:  Eur J Pediatr       Date:  1992-04       Impact factor: 3.183

7.  Transfusion Transmissible Infections in Blood Donors in the Province of Bié, Angola, during a 15-Year Follow-Up, Imply the Need for Pathogen Reduction Technologies.

Authors:  Luis Baião Peliganga; Vinicius Motta Mello; Paulo Sergio Fonseca de Sousa; Marco Aurelio Pereira Horta; Álvaro Domingos Soares; João Pedro da Silva Nunes; Miguel Nobrega; Lia Laura Lewis-Ximenez
Journal:  Pathogens       Date:  2021-12-17
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.